Mirae Asset Global Investments
CRL icon

Mirae Asset Global Investments’s Charles River Laboratories CRL Stock Holding History

Mirae Asset Global Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Buy
10,875
+883
+9% +$157K ﹤0.01% 746
2026
Q1 		$1.72M Buy
9,992
+1,715
+21% +$318K ﹤0.01% 768
2025
Q4 		$1.65M Buy
8,277
+1,192
+17% +$216K ﹤0.01% 819
2025
Q3 		$1.11M Buy
7,085
+633
+10% +$101K ﹤0.01% 868
2025
Q2 		$979K Buy
6,452
+334
+5% +$44.5K ﹤0.01% 836
2025
Q1 		$952K Buy
6,118
+817
+15% +$137K ﹤0.01% 822
2024
Q4 		$987K Buy
5,301
+1,679
+46% +$323K ﹤0.01% 820
2024
Q3 		$718K Sell
3,622
-1,137
-24% -$236K ﹤0.01% 891
2024
Q2 		$987K Sell
4,759
-5,954
-56% -$1.35M ﹤0.01% 766
2024
Q1 		$2.6M Sell
10,713
-4,045
-27% -$966K 0.01% 1071
2023
Q4 		$3.5M Sell
14,758
-638
-4% -$125K 0.01% 1025
2023
Q3 		$3.01M Sell
15,396
-3,693
-19% -$758K 0.01% 1017
2023
Q2 		$4M Buy
19,089
+479
+3% +$95.3K 0.01% 956
2023
Q1 		$3.72M Buy
18,610
+2,207
+13% +$500K 0.01% 949
2022
Q4 		$3.61M Buy
16,403
+4,123
+34% +$900K 0.01% 922
2022
Q3 		$2.38M Buy
+12,280
New +$2.65M 0.01% 1064
2021
Q4 		– Sell
-1,715
Closed -$707K – 1609
2021
Q3 		$707K Buy
1,715
+550
+47% +$228K ﹤0.01% 1406
2021
Q2 		$431K Buy
+1,165
New +$389K ﹤0.01% 1493
2019
Q3 		– Sell
-8,420
Closed -$1.2M – 1430
2019
Q2 		$1.2M Buy
+8,420
New +$1.14M 0.01% 853

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Mirae Asset Global Investments's CRL Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Charles River Laboratories (CRL) stake by 8.8% in Q2 2026, buying an estimated $157K and bringing the position to 10,875 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #746.

Mirae Asset Global Investments first reported a position in CRL in Q2 2019 and has held it in 19 quarters since. The position peaked at $4M in Q2 2023. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Mirae Asset Global Investments held 10,875 shares of Charles River Laboratories worth $2.47M as of Q2 2026.
  • Mirae Asset Global Investments bought 883 Charles River Laboratories shares in Q2 2026, an estimated $157K.
  • Charles River Laboratories made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #746 holding.
  • Mirae Asset Global Investments first reported a position in Charles River Laboratories in Q2 2019 and has held it in 19 quarters since.
  • Mirae Asset Global Investments's Charles River Laboratories position peaked at $4M in Q2 2023.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.